A major investor in the BNC ecosystem has publicly challenged board governance, alleging defensive tactics including poison pill provisions and bylaw modifications designed to obstruct shareholder oversight. The dispute centers on a delayed annual shareholder meeting, scheduled well beyond mid-December, alongside disagreement over the protocol's treasury allocation strategy. The investor contests a potential pivot in blockchain focus, questioning whether the organization should maintain commitment to one chain or explore alternatives—a decision with significant implications for ecosystem liquidity and developer activity. These governance tensions surfaced in regulatory filings, highlighting the friction between institutional stakeholders and board leadership on strategic direction. The standoff reflects broader Web3 governance challenges as protocols scale and stakeholder interests diverge.